Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Alopecia areata negatively affects self-esteem, relationships, and academics in young people.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Spironolactone is effective and safe for treating acne.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

People with alopecia areata face different healthcare access and experiences based on their race and ethnicity.

Stem cells show promise for hair regrowth, but challenges remain.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Dermatology residency programs need better DEI training to improve care for diverse patients.

Sunscreen use may increase the risk of frontal fibrosing alopecia.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

New treatments offer hope for better managing hidradenitis suppurativa.

Vitamin D supplementation can improve skin health and appearance.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

10% hPL is best for growing mesenchymal stem cells, while 10% FBS is best for hepatocytes.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Patients need better information about the risks of long-term steroid use.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.